Use of Angiotensin System Inhibitors Is Associated with Immune Activation and Longer Survival in Nonmetastatic Pancreatic Ductal AdenocarcinomaHao Liu, Kamila Naxerova, Matthias Pinter et al.|Clinical Cancer Research|2017Cited by 102